Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Aktivax, Inc. has 4 pending office actions in Medical Devices & Mechanical Engineering. The work is distributed among 4 distinct examiners and 3 distinct art units, combining examiner-level dispersion with some art-unit overlap.
GOLOVAN, MARK is the busiest examiner with 1 pending action. The absence of a dominant examiner supports matter-specific response planning, while the repeated art-unit assignments may justify checking for recurring examination themes.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLOVAN, MARK | 1 | 66.7% | +50.0% |
| ZADEH, BOB | 1 | 76.9% | +38.7% |
| SEBASCO CHENG, STEPHANIE | 1 | 58.6% | +71.1% |
| SMALE, AVERY E | 1 | 72.4% | +19.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682574 | TRANSVERSE FORCE ACTIVATED PRESSURE VESSEL | ZADEH, BOB | 42d overdue |
| 18701529 | DEAD VOLUME REDUCING CONNECTOR | GOLOVAN, MARK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682574 | TRANSVERSE FORCE ACTIVATED PRESSURE VESSEL | ZADEH, BOB | 42d overdue |
| 18183117 | ADMINISTRATION DEVICE INCORPORATING A DEFORMABLE STOPPER | SEBASCO CHENG, STEPHANIE | 23d overdue |
| 17360850 | AUTO-INJECTOR WITH UNIFORM PRESSURE EXERTION OF A PRIMARY CONTAINER | SMALE, AVERY E | 5d overdue |
| 18701529 | DEAD VOLUME REDUCING CONNECTOR | GOLOVAN, MARK | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 3754 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18701529 | DEAD VOLUME REDUCING CONNECTOR | GOLOVAN, MARK | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18682574 | TRANSVERSE FORCE ACTIVATED PRESSURE VESSEL | ZADEH, BOB | 3754 | §102§103 | Final Rejection | 42d overdue | Pending | Feb 09, 2024 |
| 18183117 | ADMINISTRATION DEVICE INCORPORATING A DEFORMABLE STOPPER | SEBASCO CHENG, STEPHANIE | 3741 | §103 | Final Rejection | 23d overdue | Pending | Mar 13, 2023 |
| 17360850 | AUTO-INJECTOR WITH UNIFORM PRESSURE EXERTION OF A PRIMARY CONTAINER | SMALE, AVERY E | 3783 | §102 | Non-Final OA | 5d overdue | Pending | Jun 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAktivax, Inc. has 4 pending office actions as of November 2026, spread across 3 art units and 4 examiners.
Mark Golovan has the most, with 1 of Aktivax, Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.